Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.27
HEWA's Cash to Debt is ranked lower than
70% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.65 vs. HEWA: 0.27 )
Ranked among companies with meaningful Cash to Debt only.
HEWA' s 10-Year Cash to Debt Range
Min: 0  Med: 1.65 Max: No Debt
Current: 0.27
Equity to Asset -2.51
HEWA's Equity to Asset is ranked lower than
100% of the 334 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.45 vs. HEWA: -2.51 )
Ranked among companies with meaningful Equity to Asset only.
HEWA' s 10-Year Equity to Asset Range
Min: -4.37  Med: 0.48 Max: 0.84
Current: -2.51
-4.37
0.84
F-Score: 5
Z-Score: -32.53
M-Score: -4.76
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -27.00
HEWA's Operating margin (%) is ranked lower than
95% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.82 vs. HEWA: -27.00 )
Ranked among companies with meaningful Operating margin (%) only.
HEWA' s 10-Year Operating margin (%) Range
Min: -145.68  Med: -28.27 Max: 3.92
Current: -27
-145.68
3.92
Net-margin (%) -27.85
HEWA's Net-margin (%) is ranked lower than
96% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.74 vs. HEWA: -27.85 )
Ranked among companies with meaningful Net-margin (%) only.
HEWA' s 10-Year Net-margin (%) Range
Min: -142.82  Med: -31.75 Max: 6.86
Current: -27.85
-142.82
6.86
ROA (%) -113.44
HEWA's ROA (%) is ranked lower than
100% of the 353 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.50 vs. HEWA: -113.44 )
Ranked among companies with meaningful ROA (%) only.
HEWA' s 10-Year ROA (%) Range
Min: -307.05  Med: -43.32 Max: 12.84
Current: -113.44
-307.05
12.84
ROC (Joel Greenblatt) (%) -249.72
HEWA's ROC (Joel Greenblatt) (%) is ranked lower than
98% of the 353 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.55 vs. HEWA: -249.72 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HEWA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -958.37  Med: -273.28 Max: 16
Current: -249.72
-958.37
16
Revenue Growth (3Y)(%) -41.50
HEWA's Revenue Growth (3Y)(%) is ranked lower than
98% of the 293 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. HEWA: -41.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HEWA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -62.1  Med: -28.60 Max: 84.2
Current: -41.5
-62.1
84.2
EBITDA Growth (3Y)(%) -54.70
HEWA's EBITDA Growth (3Y)(%) is ranked lower than
97% of the 261 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.80 vs. HEWA: -54.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HEWA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -79.5  Med: -14.40 Max: 98.8
Current: -54.7
-79.5
98.8
EPS Growth (3Y)(%) -50.60
HEWA's EPS Growth (3Y)(%) is ranked lower than
97% of the 222 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.60 vs. HEWA: -50.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HEWA' s 10-Year EPS Growth (3Y)(%) Range
Min: -77.9  Med: -17.20 Max: 86.1
Current: -50.6
-77.9
86.1
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.64
HEWA's P/S is ranked lower than
56% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.52 vs. HEWA: 0.64 )
Ranked among companies with meaningful P/S only.
HEWA' s 10-Year P/S Range
Min: 0.28  Med: 1.49 Max: 29.23
Current: 0.64
0.28
29.23
Current Ratio 0.16
HEWA's Current Ratio is ranked lower than
99% of the 336 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. HEWA: 0.16 )
Ranked among companies with meaningful Current Ratio only.
HEWA' s 10-Year Current Ratio Range
Min: 0.06  Med: 1.57 Max: 5.83
Current: 0.16
0.06
5.83
Quick Ratio 0.13
HEWA's Quick Ratio is ranked lower than
98% of the 336 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.75 vs. HEWA: 0.13 )
Ranked among companies with meaningful Quick Ratio only.
HEWA' s 10-Year Quick Ratio Range
Min: 0.02  Med: 0.94 Max: 5.83
Current: 0.13
0.02
5.83
Days Inventory 25.85
HEWA's Days Inventory is ranked higher than
65% of the 344 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 37.77 vs. HEWA: 25.85 )
Ranked among companies with meaningful Days Inventory only.
HEWA' s 10-Year Days Inventory Range
Min: 15.79  Med: 88.02 Max: 353.13
Current: 25.85
15.79
353.13
Days Sales Outstanding 6.79
HEWA's Days Sales Outstanding is ranked higher than
64% of the 286 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.39 vs. HEWA: 6.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
HEWA' s 10-Year Days Sales Outstanding Range
Min: 2.96  Med: 48.49 Max: 98.7
Current: 6.79
2.96
98.7

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.43
HEWA's Price/Median PS Value is ranked higher than
95% of the 341 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.18 vs. HEWA: 0.43 )
Ranked among companies with meaningful Price/Median PS Value only.
HEWA' s 10-Year Price/Median PS Value Range
Min: 0.21  Med: 0.92 Max: 12.5
Current: 0.43
0.21
12.5
Earnings Yield (Greenblatt) (%) -26.27
HEWA's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.50 vs. HEWA: -26.27 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HEWA' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -26.3  Med: 149.50 Max: 818
Current: -26.27
-26.3
818

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
HealthWarehouse.com Inc was incorporated in the State of Delaware on August 5, 1998. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter medical products. The Company is presently licensed as a mail-order pharmacy for sales to 50 states in the United States and the District of Columbia. Currently, it sells prescription drugs both brand name and generic; diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering allergy and sinus to pain and fever to smoking cessation aids; diet and nutritional products including supplements, weight loss aids, and vitamins and minerals and pet medications. It also provides 90-day return policy with no restocking fees, and 100% free standard shipping on all orders. It sells directly to individual consumers who purchase prescription medications and OTC products. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's business is centered on Internet-based advertising. The Company filed for a trademark on the name HealthWarehouse.com on August 14, 2007 with the U.S. Patent and Trademark Office, which trademark was granted with a registration date of May 19, 2009. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.
» More Articles for HEWA

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
HealthWarehouse.com and RxREVU Partner to Provide Drug Price Transparency to Consumers Jun 11 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 28 2015
HealthWarehouse.com to Present at the 2015 Marcum MicroCap Conference May 26 2015
HEALTHWAREHOUSE.COM, INC. Financials May 20 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 20 May 20 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 14 2015
HealthWarehouse.com Reports 9.3% Sales Growth Quarter over Quarter May 14 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report May 11 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 03 2015
HealthWarehouse.com Reports 2014 Annual Results Apr 02 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-K, Annual Report Mar 30 2015
HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital Mar 18 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 11 2015
HealthWarehouse.com Responds to Senator Klobuchar & McCain On Reintroduction of Canadian Pharmacy... Jan 27 2015
HealthWarehouse.com Relaunches Website for Consumers Who Pay out of Pocket for Prescriptions Jan 07 2015
HealthWarehouse.com Reports Third Quarter 2014 Results Nov 24 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report Nov 14 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial... Oct 29 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Change in Directors or Principal Officers Oct 22 2014
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 21 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK